SLIT2 and metabolic dysfunction-associated steatotic liver disease: Slit2 in particular was specific to PMSCs, and SLIT2+ myofibroblasts were identified in the fibrotic niche of cirrhotic human liver of varying etiologies including MASLD, suggesting that PMSC-derived myofibroblasts may contribute to scar deposition in human MASLD (96).